ZJT-23171-50439

1 vaccination 8 coded responses 14 check-ins 8 free-text entries 8 call cases

Sex: Female
Age at first dose: 41-45
ZIP prefix: 214 / MD
Registered: 2021-01-07

Relationship: Self
Race: White
Ethnicity: Not Hispanic or Latino

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-01-06
Dose 1 — Pfizer-BioNTech
2021-01-07
Registered in v-safe
2021-01-07
Survey response — days 1–6 daily, dose 1
MedDRA: Anaphylactic reaction — Feeling: Fair · Site: Pain · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit

Free text: Systemic reaction (other): Anaphylaxis following shot · Healthcare visit (other): Anaphylaxis

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-07
Report sent to call center — days 1–6 daily, dose 1
Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-01-08
Survey response — days 1–6 daily, dose 1
MedDRA: Chest discomfort, Oropharyngeal pain, Painful respiration — Feeling: Fair · Be unable to do your normal daily activities

Free text: Sore throat, pain with breathing, chest tightness

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-08
Report sent to call center — days 1–6 daily, dose 1
Be unable to do your normal daily activities

1 call case(s)
2021-01-09
Survey response — days 1–6 daily, dose 1
MedDRA: Chest discomfort, Painful respiration — Feeling: Fair · Diarrhea, Abdominal pain · Be unable to do your normal daily activities

Free text: Painful respirations, chest pressure

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-09
Report sent to call center — days 1–6 daily, dose 1
Be unable to do your normal daily activities

1 call case(s)
2021-01-10
Survey response — days 1–6 daily, dose 1
MedDRA: Dyspnoea — Feeling: Fair · Be unable to do your normal daily activities

Free text: Shortness of breath

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-10
Report sent to call center — days 1–6 daily, dose 1
Be unable to do your normal daily activities

1 call case(s)
2021-01-12
Survey response — days 1–6 daily, dose 1
MedDRA: Dyspnoea, Tachycardia, Urticaria — Feeling: Fair · Be unable to do your normal daily activities

Free text: Shortness of breath, tachycardia, hives

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-12
Report sent to call center — days 1–6 daily, dose 1
Be unable to do your normal daily activities

1 call case(s)
2021-01-13
Survey response — day 7, dose 1
MedDRA: Chest discomfort, Dyspnoea, Tachycardia — Feeling: Fair · Rash, not including the immediate area around the injection site · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Shortness of breath and chest pressure, tachycardia with activities

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-13
Report sent to call center — day 7, dose 1
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-01-21
Survey response — day 14, dose 1
MedDRA: Chest pain, Dyspnoea, Nausea — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Now off steroids and shortness of breath, chest pain, abdominal pain and nausea have returned

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-21
Report sent to call center — day 14, dose 1
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-01-27
Health check-in — day 21, dose 1
Feeling: Fair

Adult check-in
2021-02-03
Health check-in — day 28, dose 1
Feeling: Fair

Adult check-in
2021-02-08
Call successful
Reported to VAERS voluntarily prior to GDIT contact
2021-02-10
Health check-in — day 35, dose 1
Feeling: Fair

Adult check-in
2021-02-18
Health check-in — day 42, dose 1
Feeling: Good

Adult check-in
2021-04-07
Health check-in — 3 months, dose 1
Feeling: Good

Adult check-in
2021-07-07
Health check-in — 6 months, dose 1
Feeling: Fair

Adult check-in
2022-01-06
Survey response — 12 months, dose 1
MedDRA: Cough, Dyspnoea, Fatigue, Headache, Oropharyngeal pain, Pyrexia — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Shortness of breath, cough, fever, headache, sore throat, fatigue

MedDRA releases: 2024-11 · check-in free text available
2022-01-06
Report sent to call center — 12 months, dose 1
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · 1 call case(s)
2022-01-07
Call successful
Reported to VAERS voluntarily prior to GDIT contact

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-01-06	Pfizer-BioNTech

Call center

Reported	Outcome	VAERS-related outcome
2021-01-07	Successful	Reported to VAERS voluntarily prior to GDIT contact
2021-01-08	Successful	Reported to VAERS voluntarily prior to GDIT contact
2021-01-09	Successful	Reported to VAERS voluntarily prior to GDIT contact
2021-01-10	Successful	Reported to VAERS voluntarily prior to GDIT contact
2021-01-12	Successful	Reported to VAERS voluntarily prior to GDIT contact
2021-01-13	Successful 2021-02-08	Reported to VAERS voluntarily prior to GDIT contact
2021-01-21	Successful	Reported to VAERS voluntarily prior to GDIT contact
2022-01-06	Successful 2022-01-07	Reported to VAERS voluntarily prior to GDIT contact

Free text

Release 1 — days 1–6 daily, dose 1

2021-01-07

Systemic reaction (other): Anaphylaxis following shot

Healthcare visit (other): Anaphylaxis

2021-01-08

Systemic reaction (other): Sore throat, pain with breathing, chest tightness

2021-01-09

Systemic reaction (other): Painful respirations, chest pressure

2021-01-10

Systemic reaction (other): Shortness of breath

2021-01-12

Systemic reaction (other): Shortness of breath, tachycardia, hives

Release 1 — day 7, dose 1

2021-01-13

Systemic reaction (other): Shortness of breath and chest pressure, tachycardia with activities

Release 2 — day 14, dose 1

2021-01-21

Symptoms: Now off steroids and shortness of breath, chest pain, abdominal pain and nausea have returned

Release 10 — 12 months, dose 1

2022-01-06

Symptoms: Shortness of breath, cough, fever, headache, sore throat, fatigue

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
HCVO	Anaphylactic reaction	✓	✓	✓
HCVO	Medical counselling	○	○	○
SD	Chest pain	✓	✓	✓
SD	Cough	·	·	✓
SD	Dyspnoea	✓	✓	✓
SD	Fatigue	·	·	✓
SD	Headache	·	·	✓
SD	Nausea	✓	✓	✓
SD	Oropharyngeal pain	·	·	✓
SD	Pyrexia	·	·	✓
SRO	Anaphylactic reaction	✓	✓	✓
SRO	Chest discomfort	✓	✓	✓
SRO	Dyspnoea	✓	✓	✓
SRO	Oropharyngeal pain	✓	✓	✓
SRO	Painful respiration	✓	✓	✓
SRO	Tachycardia	✓	✓	✓
SRO	Urticaria	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release